multi source·15h ago·6 sources analyzed
White House Announces Deal with Regeneron to Lower Drug Prices
The White House has announced a deal with Regeneron aimed at reducing drug prices for Medicaid. This agreement is part of a broader initiative to align U.S. drug costs with those in other developed nations. (sources: pbs, thehill, washingtonpost, ap, notus)
Image: ap
ModernAction Briefing
The deal involves Regeneron voluntarily cutting prices as part of the White House's 'most favored nation' plan. This marks the final commitment from manufacturers under this initiative.
- The deal with Regeneron aims to lower drug prices for Medicaid.
- This agreement is part of the White House's 'most favored nation' plan.
- Regeneron is the last manufacturer to commit to this initiative.
Why it matters
The agreement could impact drug affordability for Medicaid recipients and reflects ongoing efforts to address healthcare costs.
No specific legislation identified for action yet.
Top coverage · 6 sources